Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103953681 | 10395368 | 1 | I | 20110707 | 20110906 | 20130103 | 20130103 | PER | DSA_47276_2011 | VALEANT | 39.00 | YR | F | N | 80.00000 | LBS | 20121219 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103953681 | 10395368 | 1 | PS | XENAZINE 12.5 MG (NOT SPECIFIED) | 1 | ORAL | D | D | 0 | 12.5 | MG | TID | |||||||
| 103953681 | 10395368 | 3 | C | TRIVORA | 1 | 0 | |||||||||||||
| 103953681 | 10395368 | 5 | C | LANSOPRAZOLE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103953681 | 10395368 | 1 | Huntington's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103953681 | 10395368 | CA |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103953681 | 10395368 | Headache | |
| 103953681 | 10395368 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 103953681 | 10395368 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103953681 | 10395368 | 1 | 20110706 | 0 |